Built by the people who lived the problems

Greg co-founded InfinityRx after nearly two decades operating inside pharmacy across specialty, retail, corporate, and independent environments. He co-founded three independent pharmacies, one of which landed on the INC 5000 as the 46th fastest-growing healthcare company in the country, before the group was acquired by private equity. He also built DermSource®, a specialized GPO now serving over 800 independent pharmacies. In 2022, Greg secured the InfinityRx foundational patent for a proprietary claims processing platform built exclusively for pharma and biotech. That architecture is the foundation every InfinityRx program runs on today. Named one of the 10 Most Emerging Leaders in Healthcare in 2021. Recognized at the 2026 Noble Business Awards with Two Gold and One Silver Leadership Honors. Read Greg's insights →

Arthur leads commercial strategy and partnerships at InfinityRx. He started his career as an ICU nurse practitioner and stepped into academia as an adjunct professor before moving into business, facilitating over 300 real estate transactions exceeding $100M and co-founding a cloud-based real estate platform that managed 1.9M+ properties before its successful exit. In healthcare, he's led investment and strategic exit planning for a multi-site pharmacy chain. At InfinityRx, Arthur translates manufacturer access and affordability priorities into program structure, bringing a builder's mindset to every partnership. Read Arthur's insights →

Abbey runs operations across the full InfinityRx platform, including claims processing, program implementation, and the operational design behind InfinityRx Claims Processor® and DermSource®. With InfinityRx since 2017, she's been integral to the company's progression from concept to scaled infrastructure. Active member of NCPDP, where she contributes to the standards work shaping affordable healthcare delivery. Abbey's discipline: turning ambitious program design into flawless execution at scale.

Kevin leads the engineering organization behind InfinityRx Claims Processor®, the company's patented adjudication platform. Over a decade of fintech and enterprise infrastructure experience at Comcast, JP Morgan, and Deutsche Bank gives him the rigor demanded by manufacturer-grade SLAs. At InfinityRx, Kevin owns the technology roadmap, platform reliability, and the integration architecture that lets InfinityRx launch programs in 1 to 2 weeks on owned infrastructure.

Keith brings 34+ years building and delivering pharmacy benefits software and operations to the InfinityRx product organization. He's served as General Manager and CIO across software companies and PBMs, and consulted with McKesson, Aetna, and Anthem. At InfinityRx, Keith leads the tech team driving the product roadmap forward, applying decades of PBM-side perspective to build infrastructure that finally works for the manufacturer instead of around them.

Peter Towle is a healthcare technology CFO with 25 years of leading finance and operations for early-stage technology companies. He has served as CFO, COO, and General Manager across venture-backed startups and as a division leader within a Fortune 50 subsidiary. 
Peter spent 13 years at mscripts, a digital engagement platform delivering medication adherence solutions to pharmacies and pharmaceutical companies. Joining in 2012 as CFO, he led the company's acquisition by Cardinal Health (NYSE: CAH) in 2019 and managed the integration into Cardinal Health's Outcomes division. He subsequently took on P&L responsibility for the mscripts business unit, growing revenue by 50% and EBITDA by 100%. 

Peter currently serves as fractional CFO for three healthcare technology companies, partnering with executive teams on strategy, financial modeling, and fundraising.

Prior to mscripts, Peter served as both full-time and fractional CFO across a range of industries. He began his career in equity research at Montgomery Securities (Bank of America). 

Christine brings more than 20 years of experience in patient services, market access, reimbursement, HUB operations, and specialty distribution, with leadership roles at Vertex Pharmaceuticals, Merck, Acceleron Pharma, Flexion Therapeutics, Chiasma, and AppliedVR.

Throughout her career, she has built and scaled patient support and access programs supporting major launches including ZILRETTA®, MYCAPSSA®, and RelieVRx®, with responsibility spanning reimbursement, medical benefit, HUB strategy, specialty pharmacy, trade and distribution, and vendor management.
She has also advised pharmaceutical manufacturers on patient support program design, HUB vendor selection, commercialization, and distribution strategy, including the development of end-to-end support models for biosimilars and oncology programs.

At InfinityRx, Christine serves as Vice President, Medical Benefit & Strategy, bringing deep manufacturer-side expertise to help expand our medical benefit, patient access, and GTN capabilities.

With more than 20 years of experience in the pharmaceutical industry, Maria is a strategic leader dedicated to helping pharmaceutical brands develop patient affordability solutions that improve access, optimize financial performance, and support long-term brand success. She combines deep industry expertise with analytical thinking, operational excellence, and a client-focused approach to deliver solutions that create meaningful business impact.

Her expertise includes patient affordability strategy, copay offer optimization, and Gross-to-Net (GTN) management. She partners closely with clients to design data-driven, scalable programs that maximize return on investment while enhancing the patient experience. By translating complex data into actionable insights, she helps organizations make informed decisions that balance commercial objectives with patient needs.

Kevin O'Meara serves as Vice President of Strategic Accounts & Growth at InfinityRx, where he partners with pharmaceutical manufacturers to develop innovative affordability, patient access, and reimbursement strategies that improve patient outcomes and drive commercial success. With more than three decades of leadership experience, Kevin helps manufacturers navigate an evolving reimbursement landscape through innovative strategies, technology-enabled solutions, and strategic partnerships.

Prior to joining InfinityRx, Kevin held executive leadership positions with EVERSANA, ConnectiveRx, and Aprecia Pharmaceuticals. Earlier, he spent 15 years with Procter & Gamble Pharmaceuticals in leadership roles across the United States, Australia, and Japan before joining AbbVie, through its legacy Actavis and Warner Chilcott organizations, where he led market access, managed markets, patient services, pricing strategy, and commercial operations.

Throughout his career, Kevin has helped shape innovative approaches to patient access, affordability, and reimbursement by commercializing new solutions, building strategic partnerships, and working closely with pharmaceutical manufacturers to improve patient access while delivering measurable business value. Kevin earned both his MBA, with concentrations in Marketing and Finance, and his Bachelor of Business Administration in Accountancy from the University of Notre Dame. He is a Certified Public Accountant (CPA), bringing a unique blend of strategic marketing expertise, financial acumen, and deep patient access expertise to every client engagement.